Director Sinha Vikas sold Scholar Rock Holding Corp ($SRRK) shares once on the open market in the last year, totaling about $715 thousand, with the latest sale on January 13, 2026; these rank 5,687th among insiders by sale value. He also sold Verona Pharma plc ($VRNA) shares six times for about 3.2 million dollars, most recently on August 1, 2025, ranking 2,626th. Among nearly 12,000 insiders with sales averaging 8.6 million dollars over 6.4 transactions each, Vikas made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | Scholar Rock Holding Corp | $SRRK | Sinha Vikas | Chief Financial Officer | A | Common Stock | 47021 | $0.00 | 630,266.0000 | 114,701,154 | 8.06% | 0.04% |
| Jan. 13, 2026 | Scholar Rock Holding Corp | $SRRK | Sinha Vikas | Chief Financial Officer | S | Common Stock | 16755 | $42.70 | 583,245.0000 | 114,701,154 | 2.79% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | D | Ordinary Shares | 94112 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | D | Share Options (Right to Buy) | 64000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | D | Share Options (Right to Buy) | 384 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.00% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | S | Ordinary Shares | 4328 | $13.14 | 94,112.0000 | 727,223,000 | 4.40% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Ordinary Shares | 24000 | $0.00 | 98,440.0000 | 727,223,000 | 32.24% | 0.00% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | S | Ordinary Shares | 39616 | $8.92 | 74,440.0000 | 652,311,000 | 34.73% | 0.01% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Share Options (Right to Buy) | 120384 | $0.00 | 0.0000 | 652,311,000 | 100.00% | 0.02% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Ordinary Shares | 39616 | $0.50 | 114,056.0000 | 652,311,000 | 53.22% | 0.01% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | S | Ordinary Shares | 120384 | $8.92 | 74,440.0000 | 652,311,000 | 61.79% | 0.02% |
| May 20, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | S | Ordinary Shares | 160000 | $9.39 | 74,440.0000 | 652,311,000 | 68.25% | 0.02% |
| May 20, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Ordinary Shares | 160000 | $0.50 | 234,440.0000 | 652,311,000 | 214.94% | 0.02% |
| May 20, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Share Options (Right to Buy) | 160000 | $0.00 | 384.0000 | 652,311,000 | 99.76% | 0.02% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Ordinary Shares | 120384 | $1.70 | 194,824.0000 | 652,311,000 | 161.72% | 0.02% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Share Options (Right to Buy) | 39616 | $0.00 | 160,384.0000 | 652,311,000 | 19.81% | 0.01% |
| May 2, 2025 | Scholar Rock Holding Corp | $SRRK | Sinha Vikas | Chief Financial Officer | A | Stock Option (Right to Buy) | 110067 | $0.00 | 110,067.0000 | 111,838,272 | 9999.99% | 0.10% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | S | Ordinary Shares | 15048 | $8.92 | 74,440.0000 | 652,311,000 | 16.82% | 0.00% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Ordinary Shares | 15048 | $1.70 | 89,488.0000 | 652,311,000 | 20.21% | 0.00% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Ordinary Shares | 4952 | $0.50 | 79,392.0000 | 652,311,000 | 6.65% | 0.00% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | S | Ordinary Shares | 4952 | $8.92 | 74,440.0000 | 652,311,000 | 6.24% | 0.00% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Share Options (Right to Buy) | 15048 | $0.00 | 80,952.0000 | 652,311,000 | 15.68% | 0.00% |
| April 29, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | M | Share Options (Right to Buy) | 4952 | $0.00 | 195,048.0000 | 652,311,000 | 2.48% | 0.00% |
| April 25, 2025 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| April 27, 2025 | Scholar Rock Holding Corp | $SRRK | Sinha Vikas | Chief Financial Officer | A | Common Stock | 100000 | $0.00 | 100,000.0000 | 111,838,272 | 9999.99% | 0.09% |
| April 27, 2025 | Scholar Rock Holding Corp | $SRRK | Sinha Vikas | Chief Financial Officer | A | Common Stock | 500000 | $0.00 | 600,000.0000 | 111,838,272 | 500.00% | 0.45% |
| Feb. 21, 2025 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 303 | $10.08 | 774,118.0000 | 0 | 0.04% | 0.00% |
| Jan. 23, 2025 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 116 | $9.45 | 774,434.0000 | 0 | 0.01% | 0.00% |
| Jan. 23, 2025 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 13 | $9.94 | 774,421.0000 | 0 | 0.00% | 0.00% |
| Jan. 10, 2025 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 979 | $0.44 | 17,814,681.0000 | 0 | 0.01% | 0.00% |
| Nov. 19, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 3186 | $0.55 | 17,815,660.0000 | 0 | 0.02% | 0.00% |
| Nov. 5, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 5136 | $0.86 | 17,818,846.0000 | 0 | 0.03% | 0.00% |
| Oct. 21, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 1546 | $0.78 | 17,825,864.0000 | 0 | 0.01% | 0.00% |
| Oct. 22, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 1882 | $0.77 | 17,823,982.0000 | 0 | 0.01% | 0.00% |
| Oct. 3, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 940 | $0.81 | 17,827,410.0000 | 0 | 0.01% | 0.00% |
| Aug. 19, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 3159 | $0.76 | 17,828,350.0000 | 0 | 0.02% | 0.00% |
| Aug. 5, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 5251 | $0.73 | 17,831,509.0000 | 0 | 0.03% | 0.00% |
| July 22, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 1858 | $0.74 | 17,836,760.0000 | 0 | 0.01% | 0.00% |
| July 19, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 1542 | $0.75 | 17,838,618.0000 | 0 | 0.01% | 0.00% |
| July 2, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 939 | $0.72 | 17,840,160.0000 | 0 | 0.01% | 0.00% |
| May 17, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 3143 | $0.75 | 17,804,762.0000 | 0 | 0.02% | 0.00% |
| May 3, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 4957 | $0.80 | 17,807,905.0000 | 0 | 0.03% | 0.00% |
| April 29, 2024 | Verona Pharma plc | $VRNA | Sinha Vikas | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |
| April 19, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 1521 | $0.75 | 17,814,719.0000 | 0 | 0.01% | 0.00% |
| April 22, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 1857 | $0.75 | 17,812,862.0000 | 0 | 0.01% | 0.00% |
| April 2, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 885 | $0.77 | 17,816,240.0000 | 0 | 0.00% | 0.00% |
| Feb. 20, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 2893 | $0.70 | 17,817,125.0000 | 0 | 0.02% | 0.00% |
| Feb. 5, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 18331 | $0.67 | 17,820,018.0000 | 0 | 0.10% | 0.00% |
| Jan. 23, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 3205 | $0.67 | 17,838,349.0000 | 0 | 0.02% | 0.00% |
| Jan. 4, 2024 | Kalaris Therapeutics, Inc. | $KLRS | Sinha Vikas | See Remarks | S | Common Stock | 961 | $0.64 | 17,841,554.0000 | 0 | 0.01% | 0.00% |